Nausicaa Clemente Selected Research

Nausicaa Clemente Research Topics

Disease

16	Neoplasms (Cancer) 01/2024 - 01/2017
7	Melanoma (Melanoma, Malignant) 11/2022 - 01/2018
5	Multiple Sclerosis 06/2021 - 09/2014
4	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2020
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2022 - 09/2014
4	Inflammation (Inflammations) 10/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 02/2014
2	Liver Diseases (Liver Disease) 11/2023 - 11/2021
2	Carcinoma (Carcinomatosis) 10/2023 - 09/2020
2	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2022 - 12/2019
2	Wounds and Injuries (Trauma) 01/2022 - 04/2018
2	Cardiotoxicity 01/2020 - 11/2019
2	Proteinuria 06/2015 - 09/2014
2	Autoimmune Lymphoproliferative Syndrome 02/2014 - 05/2012
1	Sarcopenia 04/2024
1	Muscular Atrophy (Muscle Atrophy) 04/2024
1	Osteoporosis 04/2024
1	Fibrosis (Cirrhosis) 11/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Ischemia 01/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Multiple Myeloma 01/2022
1	Sepsis (Septicemia) 01/2022
1	Neoplasm Micrometastasis 12/2021
1	Reperfusion Injury 11/2021
1	Fatty Liver 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 06/2021
1	Nervous System Diseases (Neurological Disorders) 06/2021
1	Chronic Disease (Chronic Diseases) 03/2021
1	Cystic Fibrosis (Mucoviscidosis) 03/2021
1	Celiac Disease (Celiac Sprue) 03/2021
1	Experimental Melanoma 10/2020
1	Hyperthermia 09/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2020

Drug/Important Bio-Agent (IBA)

12	OsteopontinIBA 12/2021 - 09/2014
6	CytokinesIBA 04/2024 - 02/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2019
3	Interleukin-10 (Interleukin 10)IBA 10/2020 - 09/2014
2	Monoclonal AntibodiesIBA 10/2023 - 11/2019
2	RNA (Ribonucleic Acid)IBA 10/2023 - 07/2019
2	Nicotinamide PhosphoribosyltransferaseIBA 10/2023 - 01/2020
2	Drug CombinationsIBA 11/2022 - 05/2020
2	Peptides (Polypeptides)IBA 11/2022 - 09/2014
2	2,4-dinitrofluorobenzene sulfonic acidIBA 10/2022 - 01/2020
2	LigandsIBA 01/2022 - 12/2021
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2021 - 08/2019
2	Verteporfin (Visudyne)FDA Link 12/2021 - 08/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2021 - 08/2019
2	Temozolomide (Temodar)FDA LinkGeneric 05/2020 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 11/2019
2	AntibodiesIBA 01/2019 - 01/2017
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2016
2	PerforinIBA 01/2017 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2015
2	Death Domain ReceptorsIBA 02/2014 - 05/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024
1	RANK LigandIBA 04/2024
1	GlucocorticoidsIBA 04/2024
1	Cysteine Proteinase InhibitorsIBA 11/2023
1	NAD (NADH)IBA 10/2023
1	EnzymesIBA 10/2023
1	SodiumIBA 01/2023
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2022
1	EpitopesIBA 11/2022
1	InflammasomesIBA 01/2022
1	HydrogelsIBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2021
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 11/2021
1	Glutens (Glutelin)IBA 03/2021
1	Interferon-gamma (Interferon, gamma)IBA 03/2021
1	InterleukinsIBA 03/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 03/2021
1	Messenger RNA (mRNA)IBA 03/2021
1	Tight Junction ProteinsIBA 03/2021
1	GliadinIBA 03/2021
1	Glia Maturation Factor (GMF)IBA 09/2020
1	Bevacizumab (Avastin)FDA Link 05/2020
1	Sirolimus (Rapamycin)FDA Link 05/2020
1	Taxoids (Taxanes)IBA 02/2020
1	Docetaxel (Taxotere)FDA Link 02/2020
1	taxaneIBA 02/2020
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2020

Therapy/Procedure

12	Therapeutics 01/2024 - 01/2017
3	Drug Therapy (Chemotherapy) 09/2020 - 02/2020
2	Immunotherapy 11/2022 - 10/2020
2	Photochemotherapy (Photodynamic Therapy) 12/2021 - 08/2019
2	Injections 05/2020 - 09/2014
1	Punctures 01/2022
1	Ligation 01/2022
1	Immunomodulation 01/2022
1	Subcutaneous Injections 12/2021
1	Transplantation 11/2021
1	Total Parenteral Nutrition 05/2020